A Brief History of Breast Cancer : Part II - Evolution of surgical pathology by Lakhtakia, Ritu & Chinoy, Roshan F.
Sultan Qaboos University Med J, August 2014, Vol. 14, Iss. 3, pp. e319-322, Epub. 24TH Jul 14
Submitted 15TH Apr 13
Revision Req. 13TH May 14; Revision Recd. 18TH May 14 
Accepted 18TH May 14
The origins of pathology (Greek, pathologia = ‘study of emotions or suffering’) could perhaps date back to ancient physicians 
struggling through observations and philosophy to 
unravel the mysteries of the human body and its 
afflictions. While the recordings of the Egyptians 
(3,500–2,000 B.C.) revealed through the Edwin Smith 
Papyrus, the Mesopotamians (Code of Hammurabi, 
2200 B.C.) and the Greek civilisation (Hippocrates 
460–370 B.C.) attributed deformity and destruction 
to demonical, deitical or humoral influences,1,2,3 it was 
only during the golden Islamic age from the 8th century 
and the Renaissance period of European history that 
the earliest seeds of scientific pathological practice 
were sown. Surgery, until the last century the only 
modality to treat breast cancer, predated the evolution 
of ‘surgical’ pathology by millennia narrated in part I 
of this article.4 Technological advancement combined 
with insightful understanding of pathogenesis made 
pathology the focal point of oncological practice 
only in the 19th century. The science of breast cancer 
benefited from its emergence.
Physicians, Anatomists and 
Surgeons: Forerunners of 
macroscopic pathology
The philosopher-physicians Hippocrates and Galen, 
contemplating the origin of disease, were perhaps the 
first to attempt an understanding of ‘pathogenesis’ 
(the aetiology and mechanisms of disease causation). 
Undeniably, a more vital and demonstrable direction 
emerged in the performance of autopsies as far back 
as the 12th century by Arabian physicians Avenzoar 
(1090–1162)5,6 and Ibn Al-Nafis (1213–1288),7 
followed by Antonio Benivieni (Florence, 15th 
century), Giovanni Morgagni (Italy, early 18th century) 
and Karl von Rokitansky (Vienna, mid-19th century). 
Many of these physicians had the foresight to perform 
and record their autopsy findings. Von Rokitansky 
is believed to have performed over 30,000 autopsies 
in his lifetime. This accumulation of knowledge, 
initially aimed at teaching and research, subsequently 
generated a wealth of information on which surgeons 
could draw when dealing with live patients.8 
The practice of medicine witnessed an enviable 
intertwining between disciplines—demonstrated best 
by surgeons beginning their careers as anatomists. 
American surgeons in the 19th century, in turn initiated 
‘surgical’ pathology and the role of the surgical 
pathologist. Their astounding clinical and intra-
operative appraisals, guiding the steps of a surgical 
procedure, laid the foundation for the development of 
pathology as an independent specialty in later years.9,10 
Many of them trained under 19th century physicians of 
repute in Germany and went on to lay the foundations 
of medicine and pathology in their own country.
The English anatomist and surgeon, Sir Astley 
Paston Cooper (1768–1841), brought breast disease 
to the forefront through his prolific publications on 
a host of organs including the breast (Illustrations of 
Diseases of the Breast, 1829; Anatomy of the Breast, 
1840). Modern day oncoplastic breast surgery owes its 
principles of segmental resection to Cooper’s incisive 
exploration of breast anatomy. He lent his name to the 
eponymous Cooper’s ligaments (suspensory ligaments 
of the breast), Cooper’s disease (cystic disease of 
the breast) and Cooper’s neuralgia (neuralgia of the 
breast).11
John Collins Warren (1778–1856) of the 
Massachusetts General Hospital (MGH), Boston, and 
Joseph Colt Bloodgood (1867–1935) of Johns Hopkins 
Hospital, Baltimore, surgical pioneers of renown, drew 
the pathologist to the surgeon’s theatre of operations 
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with the promise that “the combination of energies 
which accomplishes most in surgical progress is 
that contained by the cooperation of the laboratory 
investigator with the surgeon of clinical experience”.12 
Championing the significance of macroscopic 
appearance to guide surgical options they paved the 
way for rapid diagnosis by the intra-operative frozen 
section. Warren, defying contemporary practice, 
also advocated the pre-surgical biopsy of breast 
tumours. His intense preoccupation with microscopy 
is exemplified in the extensive illustrations of breast 
tumours in a book published in 1895.13
Across the Atlantic, Sir George Lenthal Cheatle 
(1865–1951), a British surgeon, and his American 
colleague Dr. Max Cutler, not only operated and studied 
thin slices of breast tissue, but documented their 
findings for posterity in 1931, in what is recognised 
as the first modern textbook of mammary pathology, 
Tumors of the Breast, Their Pathology, Symptoms, 
Diagnosis and Treatment.12 Their prodigious 
contributions to pathogenesis included postulating 
the origin of breast cancer from mammary epithelial 
cells and changing the understanding of papillary and 
biphasic tumours.
Technological Renaissance 
and the Microscopic Eye 
The emergence of microscopy, beginning with the 
chiselling of lenses, was transformed into a new world 
of disease visualisation by the early, simple (Antonie 
Van Leeuwenhoek, 1632–1723) and compound 
(Robert Hooke, 1635–1703) microscopes.14 
The 19th century German pioneer Johannes Müller 
(1801–1858) laid the foundation for the understanding 
of the cellular character of new growths in his work On 
the fine structure and form of morbid tumors in 1838, 
leaning heavily on the clinical differences between 
benign and malignant tumours. Schwann, Henle and 
Virchow, themselves historical figures of note, were his 
protégés; Henle authored the Handbook of Rational 
Pathology (1846–1853) used extensively by students of 
the time.15 
The success of the collaboration between 
the science of optics and human biology is best 
exemplified in Virchow’s (1821–1902) medical epic 
Die Cellularpathologie, published in 1871 nearly 150 
years since the advent of microscopy. The brave new 
world of cellular pathology heralded by the ‘Father 
of Pathology’ was to unravel disease as never before. 
Virchow’s now famous aphorism omnis cellula e cellula 
(every cell stems from another cell) in 1855 resounds 
through medical history right up to the modern era 
of stem cell technology.16 His legendary contributions 
to medicine could be considered the launching pad 
for the post-Virchow era of diagnostic pathology 
as we know it today. From microscopic diagnosis to 
photomicrography (illustrating disease patterns to 
peers through publications or presentations) was just 
another short step.
While microscopy offered magnification of tissues, 
it was the innovations in tissue processing (fixation and 
embedding), microtomy (section-cutting) and finally 
the fine art of staining that allowed the pathologist’s 
eye to analyse the myriad complex tissue patterns that 
define disease.17 
Breast Cancer and the 
Pathologist: Biopsy and 
cytology take a leap forward
Once microscopy became a part of disease evaluation, 
the time was ripe for establishing departments of 
pathology in institutions, removed from the ‘gross’ 
pathology observations and recordings by surgeons. In 
1854, Dr. Barnard Jackson became the first professor 
of Morbid Anatomy at the Harvard Medical School 
(and the first in the USA). However, he was still of the 
old school—relying exclusively on macroscopy. The 
microscope was pressed into service in 1847 through 
the efforts of his friend and colleague Oliver Wendell 
Holmes.13
J. Collins Warren (1842–1927),18 grandson of 
John Collins Warren (co-founder of MGH) drew on 
his European training in surgery and pathology and 
pioneered the use of needle biopsy in the diagnosis 
of breast cancer and the frozen section (the latter 
technique has also been credited to the Johns Hopkins 
gynaecologist-pathologist, Thomas S. Cullen).19 The 
procedure revolutionised decision-making at the 
operating table. 
Notable luminaries in the saga of the various forms 
of breast neoplasia in the 20th century include New York 
pathologists, Arthur Purdy Stout (1885–1967) and 
Cushman D. Haagensen (Columbia University 1933–
1975) who elucidated the nature of papillary lesions 
and lobular neoplasia.20 At the Memorial Hospital, 
New York, Fred Stewart and Frank Foote’s lifetime 
explorations into breast disease were documented 
through their classification of tumours.21 In the latter 
half of the 20th century, John G. Azzopardi (1929–
2013) at the University of London stood as a giant 
in breast pathology. His authoritative masterpiece 
Problems in Breast Pathology has served as a bible of 
breast pathology.22
Fine-needle aspiration cytology provided a simple, 
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Lessons from the Evolution of 
Surgical Pathology in Breast 
Cancer
The history of the pathological diagnosis of breast 
cancer is a fine example of the emergence of a 
discipline driven by clinical observations and 
curiosity and fuelled by technological advances. The 
breaking point in this journey came with the advent 
of microscopy that solidified forever the superiority of 
microscopic diagnosis. It is also an excellent example 
of the achievements possible with contributions 
from physics (optics), chemistry and natural sciences 
(stains) and engineering (microscopes, microtomes 
and automation). In the last half century, immunology 
and genetics have enabled the refinement of diagnosis, 
a better understanding of tumour biology and have 
brought in targeted therapy. Genetic inputs will still 
need to be tempered and teased into context by the 
tenacity of the pathologist’s eyeballing skills, backed 
by the knowledge of the complexities of tumour 
biology. These remarkable contributions allow breast 
preservation and even a cure for a once incurable 
disease.
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